These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9062506)

  • 1. The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism.
    Dorn LD; Burgess ES; Friedman TC; Dubbert B; Gold PW; Chrousos GP
    J Clin Endocrinol Metab; 1997 Mar; 82(3):912-9. PubMed ID: 9062506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing's syndrome.
    Doherty GM; Nieman LK; Cutler GB; Chrousos GP; Norton JA
    Surgery; 1990 Dec; 108(6):1085-90. PubMed ID: 2247834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
    Khawandanah D; ElAsmar N; Arafah BM
    Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
    Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life of patients with hypothalamic-pituitary-adrenal axis dysregulations: a cohort study.
    De Bucy C; Guignat L; Niati T; Bertherat J; Coste J
    Eur J Endocrinol; 2017 Jul; 177(1):1-8. PubMed ID: 28404594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome.
    Avgerinos PC; Chrousos GP; Nieman LK; Oldfield EH; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1987 Nov; 65(5):906-13. PubMed ID: 3499448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Unilateral adrenalectomy for cortisol producing adenoma: prolonged suppression of the hypothalamus-pituitary-adrenal axis].
    Arteaga E; González G; López JM; Rodríguez JA; Codner E
    Rev Med Chil; 1990 Apr; 118(4):426-9. PubMed ID: 1966792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
    Isidori AM; Kaltsas GA; Korbonits M; Pyle M; Gueorguiev M; Meinhardt A; Metz C; Petrovsky N; Popovic V; Bucala R; Grossman AB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1834-40. PubMed ID: 11932327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EEG sleep in Cushing's disease and Cushing's syndrome: comparison with patients with major depressive disorder.
    Shipley JE; Schteingart DE; Tandon R; Pande AC; Grunhaus L; Haskett RF; Starkman MN
    Biol Psychiatry; 1992 Jul; 32(2):146-55. PubMed ID: 1330006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical Cushing's syndrome.
    Terzolo M; Reimondo G; Bovio S; Angeli A
    Pituitary; 2004; 7(4):217-23. PubMed ID: 16132200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism.
    Bourdeau I; Bard C; Noël B; Leclerc I; Cordeau MP; Bélair M; Lesage J; Lafontaine L; Lacroix A
    J Clin Endocrinol Metab; 2002 May; 87(5):1949-54. PubMed ID: 11994323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperphosphatemia after surgical correction of hypercortisolism in patients with Cushing's syndrome.
    Takuwa Y; Yamamoto M; Matsumoto T; Hata K; Ogata E
    Miner Electrolyte Metab; 1986; 12(2):119-24. PubMed ID: 3960015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent cognitive impairment following surgical treatment of Cushing's syndrome.
    Forget H; Lacroix A; Cohen H
    Psychoneuroendocrinology; 2002 Apr; 27(3):367-83. PubMed ID: 11818172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications.
    Gold PW; Loriaux DL; Roy A; Kling MA; Calabrese JR; Kellner CH; Nieman LK; Post RM; Pickar D; Gallucci W
    N Engl J Med; 1986 May; 314(21):1329-35. PubMed ID: 3010108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.